| 000 | 01160 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250512045509.0 | ||
| 264 | 0 | _c19880325 | |
| 008 | 198803s 0 0 eng d | ||
| 022 | _a0071-786X | ||
| 024 | 7 |
_a10.1007/978-3-0348-9289-6_2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLien, E J | |
| 245 | 0 | 0 |
_aRibonucleotide reductase inhibitors as anticancer and antiviral agents. _h[electronic resource] |
| 260 |
_bProgress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques _c1987 |
||
| 300 |
_a101-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aRibonucleotide Reductases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 773 | 0 |
_tProgress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques _gvol. 31 _gp. 101-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-0348-9289-6_2 _zAvailable from publisher's website |
| 999 |
_c3331780 _d3331780 |
||